GEMIN8P4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.499200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.264100E-02
Normal-vs-Stage2
3.968600E-01
Normal-vs-Stage3
5.906200E-01
Normal-vs-Stage4
1.451600E-01
Stage1-vs-Stage2
8.147000E-01
Stage1-vs-Stage3
3.650600E-01
Stage1-vs-Stage4
8.391600E-01
Stage2-vs-Stage3
6.017200E-01
Stage2-vs-Stage4
8.385800E-01
Stage3-vs-Stage4
4.199400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.529000E-01
Normal-vs-AfricanAmerican
4.217400E-01
Normal-vs-Asian
1.911200E-01
Caucasian-vs-AfricanAmerican
5.272600E-01
Caucasian-vs-Asian
1.617830E-01
AfricanAmerican-vs-Asian
5.956000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.227600E-01
Normal-vs-Female
3.866200E-01
Male-vs-Female
2.806600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.199610E-01
Normal-vs-Age(41-60Yrs)
3.411000E-01
Normal-vs-Age(61-80Yrs)
3.568000E-01
Normal-vs-Age(81-100Yrs)
3.402800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.390400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.815600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.965800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.907800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.547800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.374000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.556800E-01
Normal-vs-Daily Drinker
2.379800E-01
Normal-vs-Weekly Drinker
6.369000E-01
Normal-vs-Occasional Drinker
1.358640E-01
Normal-vs-Social Drinker
3.617000E-01
Non Drinker-vs-Daily Drinker
2.496400E-01
Non Drinker-vs-Weekly Drinker
3.763200E-01
Non Drinker-vs-Occasional Drinker
4.568100E-02
Non Drinker-vs-Social Drinker
9.049800E-01
Daily Drinker-vs-Weekly Drinker
3.625900E-02
Daily Drinker-vs-Occasional Drinker
3.321200E-01
Daily Drinker-vs-Social Drinker
3.199400E-01
Weekly Drinker-vs-Occasional Drinker
6.979000E-03
Weekly Drinker-vs-Social Drinker
2.960600E-01
Occasional Drinker-vs-Social Drinker
7.110400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.639600E-01
Normal-vs-Grade 2
2.168400E-01
Normal-vs-Grade 3
7.987800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.158400E-01
Grade 1-vs-Grade 3
6.863400E-01
Grade 1-vs-Grade 4
2.639600E-01
Grade 2-vs-Grade 3
1.091010E-01
Grade 2-vs-Grade 4
2.168400E-01
Grade 3-vs-Grade 4
7.987800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.284200E-01
Normal-vs-NonDiabetic
3.164000E-01
Diabetic-vs-NonDiabetic
3.103000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.524400E-01
Normal-vs-NoPancreatitis
3.774600E-01
Pancreatitis-vs-NoPancreatitis
2.202600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.493200E-01
Normal-vs-N1
4.236400E-01
N0-vs-N1
1.094580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.332990E-01
Normal-vs-TP53-NonMutant
2.840400E-01
TP53-Mutant-vs-TP53-NonMutant
9.862200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
